Janneke C. Ham

Cetuximab Prevents Methotrexate-Induced Cytotoxicity in Vitro through Epidermal Growth Factor Dependent Regulation of Renal Drug Transporters

Pedro Caetano-Pinto, Amer Jamalpoor, Janneke C. Ham et al. · Molecular Pharmaceutics · 2017 · 34 citations · Full text

Immunology, Cellular Pharmacology, Tumor Biology +16

Allogeneic Stem-Cell Transplantation for Blastic Plasmacytoid Dendritic Cell Neoplasm

Janneke C. Ham, Jeroen J. W. M. Janssen, James E. Boers et al. · Journal of Clinical Oncology · 2012 · 22 citations · Full text

Cell Therapy, Transplantation, Marrow Transplantation +5

Genetic Variants as Predictive Markers for Ototoxicity and Nephrotoxicity in Patients with Locally Advanced Head and Neck Cancer Treated with Cisplatin-Containing Chemoradiotherapy (The PRONE Study)

C.M.L. Driessen, Janneke C. Ham, D. Maroeska W. M. te Loo et al. · Cancers · 2019 · 21 citations · Full text

Methotrexate plus or minus cetuximab as first‐line treatment in a recurrent or metastatic (R/M) squamous cell carcinoma population of the head and neck (SCCHN), unfit for cisplatin combination treatment, a phase Ib‐randomized phase II study Commence

Janneke C. Ham, Esther van Meerten, W. Edward Fiets et al. · Head & Neck · 2020 · 18 citations · Full text

Prophylactic antibiotics reduce hospitalisations and cost in locally advanced head and neck cancer patients treated with chemoradiotherapy: A randomised phase 2 study

Janneke C. Ham, C.M.L. Driessen, Mathijs P. Hendriks et al. · European Journal of Cancer · 2019 · 13 citations

Advanced Head, Prophylactic Antibiotics, Antimicrobial Stewardship +10